Illumina Inc. sued rival DNA sequencing company BillionToOne Inc. for allegedly infringing three of its patents related to noninvasive prenatal testing methods.

Management raised full-year guidance, with Dhingra stating, "We are raising our reported revenue guidance by $20 million... and now expect revenue of $4.52 billion to $4.62 billion" and "now expect ...

Scientists wanted to know why the chatter of Alston’s singing mice sounds so much like human conversation. What they found ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...

Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...

Whole genome sequencing (WGS) delivers deep insights into genetics, but its reliability depends on aligning coverage depth and uniformity with the study’s goals. Current research and practical guides ...

On his son’s fourth birthday, Michael Prescott had his first heart attack. Prescott, who worked as a civil engineer designing bridges in Tennessee, was in his 30s, and until that day, he had appeared ...